These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7616227)

  • 21. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
    Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
    Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
    Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease.
    Bissette G; Nemeroff CB; Decker MW; Kizer JS; Agid Y; Javoy-Agid F
    Ann Neurol; 1985 Apr; 17(4):324-8. PubMed ID: 4004152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
    Sofic E; Paulus W; Jellinger K; Riederer P; Youdim MB
    J Neurochem; 1991 Mar; 56(3):978-82. PubMed ID: 1704426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
    Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds GP; Hebenstreit G; Youdim MB
    J Neural Transm; 1988; 74(3):199-205. PubMed ID: 3210014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.
    Jin L; Wang J; Jin H; Fei G; Zhang Y; Chen W; Zhao L; Zhao N; Sun X; Zeng M; Zhong C
    Eur J Neurol; 2012 Jul; 19(7):969-76. PubMed ID: 22288465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.
    Graham JM; Paley MN; Grünewald RA; Hoggard N; Griffiths PD
    Brain; 2000 Dec; 123 Pt 12():2423-31. PubMed ID: 11099445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.
    Gao L; Jiang Z; Cai Z; Cai M; Zhang Q; Ma Y; Li G; Zhao F; Ma Q
    Mol Med Rep; 2017 Dec; 16(6):8209-8215. PubMed ID: 28990041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
    Gerlach M; Ben-Shachar D; Riederer P; Youdim MB
    J Neurochem; 1994 Sep; 63(3):793-807. PubMed ID: 7519659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.
    Loeffler DA; LeWitt PA; Juneau PL; Sima AA; Nguyen HU; DeMaggio AJ; Brickman CM; Brewer GJ; Dick RD; Troyer MD; Kanaley L
    Brain Res; 1996 Nov; 738(2):265-74. PubMed ID: 8955522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?
    Halliwell B
    Acta Neurol Scand Suppl; 1989; 126():23-33. PubMed ID: 2694733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.
    Bartzokis G; Sultzer D; Mintz J; Holt LE; Marx P; Phelan CK; Marder SR
    Biol Psychiatry; 1994 Apr; 35(7):480-7. PubMed ID: 8018799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes.
    Ramos P; Santos A; Pinto NR; Mendes R; Magalhães T; Almeida A
    J Trace Elem Med Biol; 2014 Jan; 28(1):13-7. PubMed ID: 24075790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR; Forno LS; Eng LF
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains.
    Focht SJ; Snyder BS; Beard JL; Van Gelder W; Williams LR; Connor JR
    Neuroscience; 1997 Jul; 79(1):255-61. PubMed ID: 9178881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
    Ahlskog JE; Uitti RJ; Low PA; Tyce GM; Nickander KK; Petersen RC; Kokmen E
    Mov Disord; 1995 Sep; 10(5):566-73. PubMed ID: 8552107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.